Now, doctors treat illnesses based on how well other people have responded to a given treatment. Soon, they will develop a tailored response built around specific understandings of the patient, the treatment and the disease, he said. "We are discovering so much about diseases like cancer at the molecular level," said von Eschenbach, a urologic surgeon. "Much of what we have done . . . has been based on a model of empiricism."
New kind of health care is coming, says acting FDA chief | The San Diego Union-Tribune: "Andrew von Eschenbach"
BioBOOM Op/Ed: This guy gets it! Too bad it's only "Acting" head of the FDA.
- ► 2013 (23)
- ► 2008 (24)
- ► 2007 (65)
- ► 2006 (77)
- Wall Street Caves in to Anti-Science Terrorists
- The "Postive" Era of Gentically Modified Foods is...
- China promotes new typing reagent for leukemia
- New kind of health care is coming, says acting FDA...
- Possible Conflicts for Doctors Are Seen on Medical...
- Thomas Tuschl's groundbreaking work in the field o...
- Elan & Biogen plan relaunch of Tysabri
- Gene that controls the severity of asthma identifi...
- Study: Medical Research Spending Jumps
- New Orleans' Health System Faces Crisis
- Market forces block tailored medicines, says exper...
- Scientists Find Genetic Clues in Fanconi Anemia
- Glowing Mice - Jumping Genes
- Exiled from their La. labs, scientists assess thei...
- Super Bug
- Calif.'s Stem Cell Agency Awards Grants
- New Technique Tracks Stem Cells' Progress
- Study holds promise for new way to fight HIV
- Breast Cancer Risk Increased for African Americans...
- ▼ September (19)